The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Worldwide access to treatment for end-stage kidney disease: a systematic review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Self-citationIntensive glucose control improves kidney outcomes in patients with type 2 diabetes
Perkovic, V., Heerspink, H. L., Chalmers, J., Woodward, M., Jun, M., Li, Q., MacMahon, S., Cooper, M. E., Hamet, P., Marre, M., et al. (2013) · Kidney International · doi:10.1038/ki.2012.401 · Cited by 316
Self-citation
Research works printed but not linked: 19
- White, 2008, How can we achieve global equity in provision of renal replacement therapy?, Bull World Health Organ, 86, 229, 10.2471/BLT.07.041715 · DOI · Paper page
- Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 · DOI · Paper page
- Kearney, 2005, Global burden of hypertension: analysis of worldwide data, Lancet, 365, 217, 10.1016/S0140-6736(05)17741-1 · DOI · Paper page
- Barros, 2003, Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio, BMC Med Res Methodol, 3, 21, 10.1186/1471-2288-3-21 · DOI · Paper page
- Hemmelgarn, 2012, Rates of treated and untreated kidney failure in older vs younger adults, JAMA, 307, 2507, 10.1001/jama.2012.6455 · DOI
- Sparke, 2013, Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation, Am J Kidney Dis, 61, 413, 10.1053/j.ajkd.2012.10.012 · DOI
- Steyerberg, 2004, Validation and updating of predictive logistic regression models: a study on sample size and shrinkage, Stat Med, 23, 2567, 10.1002/sim.1844 · DOI · Paper page
- Lysaght, 2002, Maintenance dialysis population dynamics: current trends and long-term implications, J Am Soc Nephrol, 13, S37, 10.1681/ASN.V13suppl_1s37 · DOI · Paper page
- Grassmann, 2005, ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends, Nephrol Dial Transplant, 20, 2587, 10.1093/ndt/gfi159 · DOI · Paper page
- Anand, 2013, The gap between estimated incidence of end-stage renal disease and use of therapy, PloS One, 8, e72860, 10.1371/journal.pone.0072860 · DOI
- Jha, 2004, End-stage renal care in developing countries: the India experience, Ren Fail, 26, 201, 10.1081/JDI-120039516 · DOI
- Ehrich, 2005, Demography of paediatric renal care in Europe: organization and delivery, Nephrol Dial Transplant, 20, 297, 10.1093/ndt/gfh299 · doi:10.1093/ndt/gfh299
- Lv, 2013, Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis, Can Med Assoc J, 185, 949, 10.1503/cmaj.121468 · DOI · Paper page
- Bedford, 2012, Acute kidney injury and CKD: chicken or egg?, Am J Kidney Dis, 59, 485, 10.1053/j.ajkd.2011.09.010 · DOI
- Joshi, 2008, Global inequalities in access to cardiovascular health care: our greatest challenge, J Am Coll Cardiol, 52, 1817, 10.1016/j.jacc.2008.08.049 · DOI · Paper page
- Mazzuchi, 2006, Risk factors and prevention of end stage renal disease in Uruguay, Ren Fail, 28, 617, 10.1080/08860220600925677 · DOI
- Wei, 2010, Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs, Nephrology, 15, 108, 10.1111/j.1440-1797.2009.01154.x · DOI
- Lin, 2013, Progression of stages 3b–5 chronic kidney disease—preliminary results of Taiwan national pre-ESRD disease management program in Southern Taiwan, J Formos Med Assoc, 112, 773, 10.1016/j.jfma.2013.10.021 · DOI
- Rayner, 2014, Does community-wide chronic kidney disease management improve patient outcomes?, Nephrol Dial Transplant, 29, 644, 10.1093/ndt/gft486 · doi:10.1093/ndt/gft486
Cited by
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Self-citationCanagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Self-citationGenetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Chronic kidney disease and the global public health agenda: an international consensus
Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00820-6 · Cited by 1,374
Self-citationJager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C. (2019) · Kidney International · doi:10.1016/j.kint.2019.07.012 · Cited by 957
Self-citation
Metadata
- Authors
- Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M.-H., Lv, J., Garg, A. X., Knight, J., Rodgers, A., Gallagher, M., Kotwal, S., Cass, A., & Perkovic, V.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 385
- Issue
- 9981
- Pages
- 1975-1982
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2133169646
- Cited by
- 2,339
- References
- 4
- FWCI
- 21.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Baxter International
- Novartis
- National Health and Medical Research Council (APP100311, 105255)
- Amgen
- Merck
- Australian Government
- Australian Research Council (DP100100295)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Worldwide access to treatment for end-stage kidney disease: a systematic review. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61601-9
- The paper
- Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M.-H., Lv, J., Garg, A. X., Knight, J., Rodgers, A., Gallagher, M., Kotwal, S., Cass, A., & Perkovic, V. (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet. https://doi.org/10.1016/s0140-6736(14)61601-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.